Tempus AI (NASDAQ:TEM) Shares Up 8.6%

Tempus AI, Inc. (NASDAQ:TEM)’s stock price shot up 8.6% on Tuesday . The stock traded as high as $42.00 and last traded at $42.00. 313,622 shares were traded during mid-day trading, a decline of 73% from the average session volume of 1,182,351 shares. The stock had previously closed at $38.68.

Wall Street Analysts Forecast Growth

Several research firms have commented on TEM. Morgan Stanley began coverage on Tempus AI in a research report on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 price objective on the stock. William Blair began coverage on Tempus AI in a research report on Tuesday, July 9th. They issued an “outperform” rating on the stock. Stifel Nicolaus began coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $45.00 price objective on the stock. Needham & Company LLC restated a “buy” rating and issued a $47.00 price objective on shares of Tempus AI in a research report on Wednesday, August 7th. Finally, Loop Capital assumed coverage on Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price objective on the stock. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $45.56.

Tempus AI Price Performance

The firm has a 50-day moving average price of $36.72.

Institutional Trading of Tempus AI

Hedge funds and other institutional investors have recently modified their holdings of the business. Sandia Investment Management LP acquired a new position in Tempus AI in the 2nd quarter valued at about $136,000. Northwestern University acquired a new position in Tempus AI in the 2nd quarter valued at about $491,000. Squarepoint Ops LLC acquired a new position in Tempus AI in the 2nd quarter valued at about $633,000. WINTON GROUP Ltd acquired a new position in Tempus AI in the 2nd quarter valued at about $634,000. Finally, Scientech Research LLC acquired a new position in Tempus AI in the 2nd quarter valued at about $756,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.